Di Ruscio, M.; Lunardi, G.; Buonfrate, D.; Gobbi, F.; Bertoli, G.; Piccoli, D.; Conti, A.; Geccherle, A.; Variola, A.
A Seroprevalence Study of Anti-SARS-CoV-2 Antibodies in Patients with Inflammatory Bowel Disease during the Second Wave of the COVID-19 Pandemic in Italy. Medicina 2021, 57, 1048.
https://doi.org/10.3390/medicina57101048
AMA Style
Di Ruscio M, Lunardi G, Buonfrate D, Gobbi F, Bertoli G, Piccoli D, Conti A, Geccherle A, Variola A.
A Seroprevalence Study of Anti-SARS-CoV-2 Antibodies in Patients with Inflammatory Bowel Disease during the Second Wave of the COVID-19 Pandemic in Italy. Medicina. 2021; 57(10):1048.
https://doi.org/10.3390/medicina57101048
Chicago/Turabian Style
Di Ruscio, Mirko, Gianluigi Lunardi, Dora Buonfrate, Federico Gobbi, Giulia Bertoli, Donatella Piccoli, Antonio Conti, Andrea Geccherle, and Angela Variola.
2021. "A Seroprevalence Study of Anti-SARS-CoV-2 Antibodies in Patients with Inflammatory Bowel Disease during the Second Wave of the COVID-19 Pandemic in Italy" Medicina 57, no. 10: 1048.
https://doi.org/10.3390/medicina57101048
APA Style
Di Ruscio, M., Lunardi, G., Buonfrate, D., Gobbi, F., Bertoli, G., Piccoli, D., Conti, A., Geccherle, A., & Variola, A.
(2021). A Seroprevalence Study of Anti-SARS-CoV-2 Antibodies in Patients with Inflammatory Bowel Disease during the Second Wave of the COVID-19 Pandemic in Italy. Medicina, 57(10), 1048.
https://doi.org/10.3390/medicina57101048
